BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Product News   Aug 14, 2017

 
BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Methyltransferases have become a major focus of drug discovery for cancer and other diseases driven by epigenetic factors. BellBrook Labs’ new, ultra-sensitive AptaFluor™ SAH Methyltransferase Assay eliminates cost and sensitivity barriers that are slowing the discovery of methyltransferase inhibitors. Credit: BellBrook Labs

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Shimadzu's New Nexera Mikros Microflow LC-MS/MS System Balances High Sensitivity with Ruggedness and Elegant Design

Product News

Shimadzu Scientific Instruments (SSI) announces the release of the Nexera Mikros Microflow Liquid Chromatography Mass Spectrometry System. Covering the complete range from microflow to semi-microflow, this system allows operators to realize high sensitivity, yet with the reliability and ruggedness of HPLC.

READ MORE

Informative Spring 2018 Freeze Drying Webinars Program

Product News

The new Spring 2018 program of LyoLearn™ educational webinars has been announced by SP Scientific. Devoted to lyophilization current research interest and related topics, and delivered by industry experts, attendees to each of the free live sessions are encouraged to ask questions of the presenter and get their answers in real time.

READ MORE

LabVantage Highlights Packaged LIMS Solutions at Pittcon to Meet Industry-Specific Needs

Product News

Purpose-built, flexible LIMS solutions save time and money for pharma, food & beverage, oil & gas, and diagnostics.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Genomics Research Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE